New addition strengthens SK Biopharmaceuticals’ radiopharmaceutical therapy portfolio and reinforces its R&D capabilities through global partnerships and value chain integration…
Recognized for its end-to-end innovation, operational efficiency, and commitment to customer-centric cybersecurity services SAN ANTONIO, Nov. 26, 2025 /PRNewswire/ — Frost…